4-Chloro-6-methoxy-2-methyl-3-nitroquinoline (1) was synthesized from 4-methoxyaniline through three steps including Cyclization, Nitrification and Chlorination. The structure of the target product (1) was confirmed by 1H NMR and MS. This method started with cheap raw materials was of simple experimental operation and mild reaction conditions. It was suitable for large scale pilot study and the yield of the product is achieved to 85%.
Introduction
PI3K/Akt/mTOR signaling pathway plays an important role in tumor cell proliferation, survival, resistance to apoptosis, angiogenesis and metastasis, and resistance to radiotherapy and chemotherapy. Therefore, it is closely related with human multiple tumors. In other words, mTOR is a vital substrate along this pathway. The development of targeted therapies against mTOR led to the approval of allosteric inhibitors, for the treatment of cancers [1] . However, it remains an unresolved issue that the suboptimal duration of response is in unselected patients [2] . In view of that awaits further investigation and in multiple tumour types, there are being actively investigated for numerous novel therapies against critical nodes of this pathway in the clinic [3] . So many boffins prepared a series of quinoline derivatives, and they research their differential tissue staining and tumor growth retardation to determine antitumor activity [4] [5] .
With the efforts of a large number of scientific research workers [6] , a series of PI3K/mTOR inhibitors have come out and showed excellent anti-tumor activity and many quinazoline derivatives which exhibited potential biological activities, such as (4) have been confirmed (Fig.1) . In recent years, the product of quinolone inhibitors such as NVP-BEZ235 in tumor applications has been reported, including chemotherapy and drug combination. It is combined with other molecular targeted drugs and radiotherapy combined therapy and so on [8] [9] [10] [11] [12] .
4-Chloro-6-methoxy-2-methyl-3-nitroquinoline (1) is a key intermediate for the synthesis of quinoline inhibitors. In this paper, we summarized and optimized the synthetic methods of compound 1 according to the literature [13] . We designed and optimized the synthetic methods make it more suitable for industrial production. 
Materials and Methods
NMR spectra were performed using Bruker 400 MHz spectrometers (Bruker Bioscience, Billerica, MA, USA) with TMS as an internal standard. Mass spectra (MS) were taken in ESI mode on Agilent 1100 LC-MS (Agilent, Palo Alto, CA, USA). All the materials were obtained from commercial suppliers and used without purification, unless otherwise specified. Yields were not optimized. TLC analysis was carried out on silica gel plates GF254 (Qindao Haiyang Chemical, China).
Synthesis of Compounds
The structures and the synthetic route were shown in Scheme 1. 
Conclusions
In conclusion, one novel compound 4 was synthesized from 4-methoxyaniline through three steps. The synthetic route can be used to synthesize 4-chloro-6-methoxy-2-methyl-3-nitroquinoline. The purity of the product was much higher than before. Its structure was confirmed by MS and 1H NMR spectrum.
